BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2338886)

  • 1. 5-Hydroxytryptamine affects rat migrating myoelectric complexes through different receptor subtypes: evidence from 5-hydroxytryptophan administration.
    Sagrada A; Brancaccio N; Schiavone A
    Life Sci; 1990; 46(17):1207-16. PubMed ID: 2338886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of 5-HT1, 5-HT2, and 5-HT3 receptors in the mediation of the prolactin response to serotonin and 5-hydroxytryptophan.
    Jørgensen H; Knigge U; Warberg J
    Neuroendocrinology; 1992 Mar; 55(3):336-43. PubMed ID: 1386914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin stimulates migrating myoelectric complex via 5-HT3-receptors dependent on cholinergic pathways in rat small intestine.
    Lördal M; Hellström PM
    Neurogastroenterol Motil; 1999 Feb; 11(1):1-10. PubMed ID: 10087529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of 5-hydroxytryptamine in the intestinal motor disturbances induced by mast cell degranulation in rats.
    Bueno L; Fargeas MJ; Theodorou V; Fioramonti J
    Eur J Pharmacol; 1991 Jan; 192(2):263-9. PubMed ID: 2032558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-5-HTP facilitates the electrically stimulated flexor reflex in pithed rats: evidence for 5-HT2-receptor mediation.
    Skarsfeldt T; Arnt J; Hyttel J
    Eur J Pharmacol; 1990 Feb; 176(2):135-42. PubMed ID: 1968846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the selective 5-HT3 receptor antagonists ICS 205-930 and MDL 72222 on 5-HTP-induced head shaking and behavioral symptoms induced by 5-methoxy-N,N,dimethyltryptamine in rats: comparison with some other 5-HT receptor antagonists.
    Shearman GT; Tolcsvai L
    Psychopharmacology (Berl); 1987; 92(4):520-3. PubMed ID: 3114804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different serotonin receptor types participate in 5-hydroxytryptophan-induced gonadotropins and prolactin release in the female infantile rat.
    Lacau-Mengido IM; Libertun C; Becú-Villalobos D
    Neuroendocrinology; 1996 May; 63(5):415-21. PubMed ID: 8738578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral conversion of L-5-hydroxytryptophan to serotonin induces drinking in rats.
    Kikta DC; Threatte RM; Barney CC; Fregly MJ; Greenleaf JE
    Pharmacol Biochem Behav; 1981 Jun; 14(6):889-93. PubMed ID: 6973156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of 5-HT2 receptors in the wet-dog shake behaviour induced by 5-hydroxytryptophan in the rat.
    Yap CY; Taylor DA
    Neuropharmacology; 1983 Jul; 22(7):801-4. PubMed ID: 6604883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.
    Meller ST; Lewis SJ; Brody MJ; Gebhart GF
    Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for the involvement of 5-HT4 receptors in the 5-hydroxytryptamine-induced pattern of migrating myoelectric complex in sheep.
    Plaza MA; Arruebo MP; Murillo MD
    Br J Pharmacol; 1997 Mar; 120(6):1144-50. PubMed ID: 9134228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.
    Cheng CH; Costall B; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1994 Apr; 255(1-3):39-49. PubMed ID: 7913044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2 and 5-HT3 receptor subtypes mediate cholera toxin-induced intestinal fluid secretion in the rat.
    Beubler E; Horina G
    Gastroenterology; 1990 Jul; 99(1):83-9. PubMed ID: 2344945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central and peripheral mechanisms contribute to the antiemetic actions of delta-9-tetrahydrocannabinol against 5-hydroxytryptophan-induced emesis.
    Darmani NA; Johnson JC
    Eur J Pharmacol; 2004 Mar; 488(1-3):201-12. PubMed ID: 15044052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of chronic treatment with 5-hydroxytryptophan on cortical serotonin receptors in the rat.
    Pranzatelli MR
    Clin Neuropharmacol; 1988 Jun; 11(3):257-62. PubMed ID: 3261199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the involvement of 5-hydroxytryptamine 4 receptors in 5-hydroxytryptophan-induced diarrhea in mice.
    Hedge SS; Moy TM; Perry MR; Loeb M; Eglen RM
    J Pharmacol Exp Ther; 1994 Nov; 271(2):741-7. PubMed ID: 7965791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist and antagonist properties of serotonergic compounds in pigeons trained to discriminate either quipazine or L-5-hydroxytryptophan.
    Yamamoto T; Walker EA; Woods JH
    J Pharmacol Exp Ther; 1991 Sep; 258(3):999-1007. PubMed ID: 1890629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of 5-HT1-like receptors in the increase in intragastric pressure induced by 5-hydroxytryptamine in the rat.
    Dhasmana KM; Villalón CM; Zhu YN; Tadipatri S; Saxena PR
    Eur J Pharmacol; 1992 Mar; 213(2):293-9. PubMed ID: 1521563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.